NewslettersExtracellular Matrix NewsRTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast ReconstructionBy Emily Salmini - November 25, 20240375RTI Surgical announced the enrollment of the first patient in ADMIRE. This IDE study is designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.[RTI Surgical]Press Release